NASDAQ : SEPN
Septerna, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.05B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.05B |
| Enterprise Value | 1.56B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 46.68M |
| Shares Outstanding | 46.68M |
| Shares Change (YoY) | +45.19% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 2.86% |
| Owned by Institutions (%) | 58.69% |
| Float | 26.41M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.77 |
| Forward PS | 25.66 |
| PB Ratio | 5.20 |
| P/TBV Ratio | 5.31 |
| P/FCF Ratio | 19.54 |
| P/OCF Ratio | 19.37 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 15.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 14.84 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.99 |
| Quick Ratio | 4.90 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.21 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -6.34% |
| Return on Assets (ROA) | -7.13% |
| Return on Invested Capital (ROIC) | -123.05% |
| Return on Capital Employed (ROCE) | -11.50% |
| Weighted Average Cost of Capital (WACC) | 16.62% |
| Revenue Per Employee | $803,919 |
| Profits Per Employee | -$197,041 |
| Employee Count | 123 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.32M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.28 |
| 52-Week Price Change | +100.55% |
| 50-Day Moving Average | 38.95 |
| 200-Day Moving Average | 32.08 |
| Relative Strength Index (RSI) | 65.17 |
| Average Volume (20 Days) | 368,398 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.52M |
| Short Previous Month | 3.10M |
| Short % of Shares Out | 7.55% |
| Short % of Float | 13.34% |
| Short Ratio (days to cover) | 8.65 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 98.88M |
| Gross Profit | 98.88M |
| Operating Income | -56.05M |
| Pretax Income | -22.91M |
| Net Income | -24.24M |
| EBITDA | -54.40M |
| EBIT | -56.05M |
| Loss Per Share | -$0.54 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 372.32M |
| Total Debt | 22.55M |
| Net Cash | 493.97M |
| Net Cash Per Share | $10.58 |
| Equity (Book Value) | 386.72M |
| Book Value Per Share | 8.47 |
| Working Capital | 316.84M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 106.01M |
| Capital Expenditures | -910,000 |
| Depreciation & Amortization | 1.65M |
| Net Borrowing | n/a |
| Free Cash Flow | 105.10M |
| FCF Per Share | $2.25 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -56.68% |
| Pretax Margin | -23.17% |
| Profit Margin | -24.51% |
| EBITDA Margin | -55.01% |
| EBIT Margin | -56.68% |
| FCF Margin | 106.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -45.19% |
| Shareholder Yield | -45.19% |
| Earnings Yield | -1.23% |
| FCF Yield | 5.12% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $54.22 |
| Price Target Difference | 23.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 3.03% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.46 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |